Literature DB >> 1444583

Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid.

H Endo1, I Iwamoto, M Fujita, S Okamoto, S Yoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1444583     DOI： 10.1007/bf00372588

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  15 in total

1.  Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.

Authors:  M Plaut; J H Pierce; C J Watson; J Hanley-Hyde; R P Nordan; W E Paul
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Cellular events leading to blister formation in bullous pemphigoid.

Authors:  L Dubertret; B Bertaux; M Fosse; R Touraine
Journal:  Br J Dermatol       Date:  1980-12       Impact factor: 9.302

4.  Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.

Authors:  S A Grando; B T Glukhenky; G N Drannik; E V Epshtein; A P Kostromin; T A Korostash
Journal:  Arch Dermatol       Date:  1989-07

5.  Bullous pemphigoid blister fluid stimulates eosinophil colony formation and activates eosinophils.

Authors:  G A Varigos; G Morstyn; M A Vadas
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

6.  Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5).

Authors:  H D Campbell; W Q Tucker; Y Hort; M E Martinson; G Mayo; E J Clutterbuck; C J Sanderson; I G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  Bullous pemphigoid: a cause of peripheral blood eosinophilia.

Authors:  L L Bushkell; R E Jordon
Journal:  J Am Acad Dermatol       Date:  1983-05       Impact factor: 11.527

8.  Increased levels of immunoreactive leukotriene B4 in blister fluids of bullous pemphigoid patients and effects of a selective 5-lipoxygenase inhibitor on experimental skin lesions.

Authors:  S Kawana; A Ueno; S Nishiyama
Journal:  Acta Derm Venereol       Date:  1990       Impact factor: 4.437

9.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

10.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307
View more
  8 in total

1.  Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

Authors:  E Schmidt; B Bastian; R Dummer; H P Tony; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

2.  Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.

Authors:  R Chen; G Ning; M L Zhao; M G Fleming; L A Diaz; Z Werb; Z Liu
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)

Authors:  R F Ghohestani; E Cozzani; E Delaporte; J F Nicolas; A Parodi; A Claudy
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

4.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

Review 5.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 6.  Proteases in Pemphigoid Diseases.

Authors:  Sho Hiroyasu; Christopher T Turner; Katlyn C Richardson; David J Granville
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

Review 7.  The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.

Authors:  Hui Fang; Yang Zhang; Ning Li; Gang Wang; Zhi Liu
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

Review 8.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.